Aug 14, 2025 17:00
FBRX - Forte Biosciences, Inc. Common Stock
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 20.41 -1.5 (-7.35%) | -0.23 (-1.18%) | -0.23 (-1.18%) | -0.34 (-1.77%) | --- | -1.5 (-7.35%) | --- | --- |
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
Market
Earnings & Ratios
- Basic EPS:
- -0.96
- Diluted EPS:
- -0.96
- Basic P/E:
- -19.6979
- Diluted P/E:
- -19.6979
- RSI(14) 1m:
- 48.79
- VWAP:
- 19.06
- RVol:
Events
| Period | Kind | Movement | Occurred At |
|---|
Related News
Jul 04, 2025 10:00
Mar 25, 2024 16:00
Dec 13, 2023 13:29
Dec 11, 2023 13:34
Nov 24, 2023 11:38
Apr 06, 2023 19:53
Jul 13, 2022 08:59
Jul 12, 2022 16:00
May 03, 2022 13:33